Aptose Biosciences has postponed its special shareholder meeting originally set for January 16, 2026, to later in January, pending...

Zenas BioPharma has granted non-qualified stock options for 300,000 shares to two newly hired employees as inducement awards under...

The White House has issued an executive order directing expedited reclassification of cannabis from Schedule I to Schedule III...

Galapagos reported mixed topline readouts for its selective TYK2 inhibitor GLPG3667: a Phase 3–enabling dermatomyositis study met its primary...

Celularity has entered binding term sheets for a $7 million senior secured term loan and up to $5 million...

Iovance Biotherapeutics granted inducement stock options covering 43,150 shares to four new non-executive employees, effective December 18, 2025, at...

Zenas BioPharma granted inducement stock options covering 300,000 shares to two newly hired employees on December 15, 2025, at...

Boehringer Ingelheim has secured FDA approval for Jascayd (nerandomilast) tablets to treat progressive pulmonary fibrosis (PPF) in adults, the...

Centessa Pharmaceuticals reported positive Phase 2a results for its oral OX2R agonist, ORX750, across narcolepsy type 1, narcolepsy type...

Pharming Group posted a 30% year-over-year revenue increase to $97.3 million in Q3 2025 and lifted full-year guidance to...